Environmental toxin acrolein alters levels of endogenous lipids, including TRP agonists: A potential mechanism for headache driven by TRPA1 activation

Emma Leishman, Phillip E. Kunkler, Meera Manchanda, Kishan Sangani, Jordyn M. Stuart, Gerry S. Oxford, Joyce Hurley, Heather B. Bradshaw

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Exposure to airborne toxins can trigger headaches, but the mechanisms are not well understood. Some environmental toxins, such as acrolein, activate transient receptor potential ankyrin 1 (TRPA1), a receptor involved in pain sensation that is highly expressed in the trigeminovascular system. It has been shown in rat models that repeated exposure to acrolein induces trigeminovascular sensitization to both TRPA1 and TRP vanilloid 1 (TRPV1) agonists, a phenomenon linked to headache. In this study, we test the hypothesis that the sensitization of trigeminovascular responses in rats after acrolein exposure via inhalation is associated with changes in levels of endogenous lipids, including TRPV1 agonists, in the trigeminal ganglia, trigeminal nucleus, and cerebellum. Lipidomics analysis of 80 lipids was performed on each tissue after acute acrolein, chronic acrolein, or room air control. Both acute and chronic acrolein exposure drove widespread alterations in lipid levels. After chronic acrolein exposure, levels of all 6 N-acyl ethanolamines in the screening library, including the endogenous cannabinoid and TRPV1 agonist, N-arachidonoyl ethanolamine, were elevated in trigeminal tissue and in the cerebellum. This increase in TRPV1 ligands by acrolein exposure may indicate further downstream signaling, in that we also show here that a combination of these TRPV1 endogenous agonists increases the potency of the individual ligands in TRPV1-HEK cells. In addition to these TRPV1 agonists, 3 TRPV3 antagonists, 4 TRPV4 agonists, and 25 orphan lipids were up and down regulated after acrolein exposure. These data support the hypothesis that lipid signaling may represent a mechanism by which repeated exposure to the TRPA1 agonist and environmental toxin, acrolein, drives trigeminovascular sensitization.

Original languageEnglish (US)
Pages (from-to)28-36
Number of pages9
JournalNeurobiology of Pain
Volume1
DOIs
StatePublished - Jan 1 2017

Fingerprint

Ankyrins
Acrolein
Headache
Lipids
Cerebellum
Ethanolamines
Trigeminal Nuclei
Ligands
Inhalation Exposure
Trigeminal Ganglion
Ethanolamine
Cannabinoids
trophoblastin
Libraries
Air

Keywords

  • Acrolein
  • Endogenous cannabinoid
  • Lipidomics
  • Lipoamine
  • Migraine
  • TRPA1
  • TRPV1

ASJC Scopus subject areas

  • Neuroscience (miscellaneous)
  • Anesthesiology and Pain Medicine
  • Clinical Neurology

Cite this

Environmental toxin acrolein alters levels of endogenous lipids, including TRP agonists : A potential mechanism for headache driven by TRPA1 activation. / Leishman, Emma; Kunkler, Phillip E.; Manchanda, Meera; Sangani, Kishan; Stuart, Jordyn M.; Oxford, Gerry S.; Hurley, Joyce; Bradshaw, Heather B.

In: Neurobiology of Pain, Vol. 1, 01.01.2017, p. 28-36.

Research output: Contribution to journalArticle

Leishman, Emma ; Kunkler, Phillip E. ; Manchanda, Meera ; Sangani, Kishan ; Stuart, Jordyn M. ; Oxford, Gerry S. ; Hurley, Joyce ; Bradshaw, Heather B. / Environmental toxin acrolein alters levels of endogenous lipids, including TRP agonists : A potential mechanism for headache driven by TRPA1 activation. In: Neurobiology of Pain. 2017 ; Vol. 1. pp. 28-36.
@article{dfe29afa34964c54817b08aec331a5e5,
title = "Environmental toxin acrolein alters levels of endogenous lipids, including TRP agonists: A potential mechanism for headache driven by TRPA1 activation",
abstract = "Exposure to airborne toxins can trigger headaches, but the mechanisms are not well understood. Some environmental toxins, such as acrolein, activate transient receptor potential ankyrin 1 (TRPA1), a receptor involved in pain sensation that is highly expressed in the trigeminovascular system. It has been shown in rat models that repeated exposure to acrolein induces trigeminovascular sensitization to both TRPA1 and TRP vanilloid 1 (TRPV1) agonists, a phenomenon linked to headache. In this study, we test the hypothesis that the sensitization of trigeminovascular responses in rats after acrolein exposure via inhalation is associated with changes in levels of endogenous lipids, including TRPV1 agonists, in the trigeminal ganglia, trigeminal nucleus, and cerebellum. Lipidomics analysis of 80 lipids was performed on each tissue after acute acrolein, chronic acrolein, or room air control. Both acute and chronic acrolein exposure drove widespread alterations in lipid levels. After chronic acrolein exposure, levels of all 6 N-acyl ethanolamines in the screening library, including the endogenous cannabinoid and TRPV1 agonist, N-arachidonoyl ethanolamine, were elevated in trigeminal tissue and in the cerebellum. This increase in TRPV1 ligands by acrolein exposure may indicate further downstream signaling, in that we also show here that a combination of these TRPV1 endogenous agonists increases the potency of the individual ligands in TRPV1-HEK cells. In addition to these TRPV1 agonists, 3 TRPV3 antagonists, 4 TRPV4 agonists, and 25 orphan lipids were up and down regulated after acrolein exposure. These data support the hypothesis that lipid signaling may represent a mechanism by which repeated exposure to the TRPA1 agonist and environmental toxin, acrolein, drives trigeminovascular sensitization.",
keywords = "Acrolein, Endogenous cannabinoid, Lipidomics, Lipoamine, Migraine, TRPA1, TRPV1",
author = "Emma Leishman and Kunkler, {Phillip E.} and Meera Manchanda and Kishan Sangani and Stuart, {Jordyn M.} and Oxford, {Gerry S.} and Joyce Hurley and Bradshaw, {Heather B.}",
year = "2017",
month = "1",
day = "1",
doi = "10.1016/j.ynpai.2017.03.001",
language = "English (US)",
volume = "1",
pages = "28--36",
journal = "Neurobiology of Pain",
issn = "2452-073X",
publisher = "Elsevier BV",

}

TY - JOUR

T1 - Environmental toxin acrolein alters levels of endogenous lipids, including TRP agonists

T2 - A potential mechanism for headache driven by TRPA1 activation

AU - Leishman, Emma

AU - Kunkler, Phillip E.

AU - Manchanda, Meera

AU - Sangani, Kishan

AU - Stuart, Jordyn M.

AU - Oxford, Gerry S.

AU - Hurley, Joyce

AU - Bradshaw, Heather B.

PY - 2017/1/1

Y1 - 2017/1/1

N2 - Exposure to airborne toxins can trigger headaches, but the mechanisms are not well understood. Some environmental toxins, such as acrolein, activate transient receptor potential ankyrin 1 (TRPA1), a receptor involved in pain sensation that is highly expressed in the trigeminovascular system. It has been shown in rat models that repeated exposure to acrolein induces trigeminovascular sensitization to both TRPA1 and TRP vanilloid 1 (TRPV1) agonists, a phenomenon linked to headache. In this study, we test the hypothesis that the sensitization of trigeminovascular responses in rats after acrolein exposure via inhalation is associated with changes in levels of endogenous lipids, including TRPV1 agonists, in the trigeminal ganglia, trigeminal nucleus, and cerebellum. Lipidomics analysis of 80 lipids was performed on each tissue after acute acrolein, chronic acrolein, or room air control. Both acute and chronic acrolein exposure drove widespread alterations in lipid levels. After chronic acrolein exposure, levels of all 6 N-acyl ethanolamines in the screening library, including the endogenous cannabinoid and TRPV1 agonist, N-arachidonoyl ethanolamine, were elevated in trigeminal tissue and in the cerebellum. This increase in TRPV1 ligands by acrolein exposure may indicate further downstream signaling, in that we also show here that a combination of these TRPV1 endogenous agonists increases the potency of the individual ligands in TRPV1-HEK cells. In addition to these TRPV1 agonists, 3 TRPV3 antagonists, 4 TRPV4 agonists, and 25 orphan lipids were up and down regulated after acrolein exposure. These data support the hypothesis that lipid signaling may represent a mechanism by which repeated exposure to the TRPA1 agonist and environmental toxin, acrolein, drives trigeminovascular sensitization.

AB - Exposure to airborne toxins can trigger headaches, but the mechanisms are not well understood. Some environmental toxins, such as acrolein, activate transient receptor potential ankyrin 1 (TRPA1), a receptor involved in pain sensation that is highly expressed in the trigeminovascular system. It has been shown in rat models that repeated exposure to acrolein induces trigeminovascular sensitization to both TRPA1 and TRP vanilloid 1 (TRPV1) agonists, a phenomenon linked to headache. In this study, we test the hypothesis that the sensitization of trigeminovascular responses in rats after acrolein exposure via inhalation is associated with changes in levels of endogenous lipids, including TRPV1 agonists, in the trigeminal ganglia, trigeminal nucleus, and cerebellum. Lipidomics analysis of 80 lipids was performed on each tissue after acute acrolein, chronic acrolein, or room air control. Both acute and chronic acrolein exposure drove widespread alterations in lipid levels. After chronic acrolein exposure, levels of all 6 N-acyl ethanolamines in the screening library, including the endogenous cannabinoid and TRPV1 agonist, N-arachidonoyl ethanolamine, were elevated in trigeminal tissue and in the cerebellum. This increase in TRPV1 ligands by acrolein exposure may indicate further downstream signaling, in that we also show here that a combination of these TRPV1 endogenous agonists increases the potency of the individual ligands in TRPV1-HEK cells. In addition to these TRPV1 agonists, 3 TRPV3 antagonists, 4 TRPV4 agonists, and 25 orphan lipids were up and down regulated after acrolein exposure. These data support the hypothesis that lipid signaling may represent a mechanism by which repeated exposure to the TRPA1 agonist and environmental toxin, acrolein, drives trigeminovascular sensitization.

KW - Acrolein

KW - Endogenous cannabinoid

KW - Lipidomics

KW - Lipoamine

KW - Migraine

KW - TRPA1

KW - TRPV1

UR - http://www.scopus.com/inward/record.url?scp=85041493335&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85041493335&partnerID=8YFLogxK

U2 - 10.1016/j.ynpai.2017.03.001

DO - 10.1016/j.ynpai.2017.03.001

M3 - Article

AN - SCOPUS:85041493335

VL - 1

SP - 28

EP - 36

JO - Neurobiology of Pain

JF - Neurobiology of Pain

SN - 2452-073X

ER -